Global Medicare Advantage

Medicare Advantage Comprehensive Study by Type (Health maintenance organizations (HMO), Preferred Provider Organizations (PPO), Special Need Plans and Private Fee For Service, Medical Savings Accounts, Others), Application (Agents or Brokers, Direct Writing) Players and Region - Global Market Outlook to 2030

Medicare Advantage Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Medicare Advantage
Health insurers compete by offering new pricing and product options to beneficiaries during the Open Enrollment Period for Medicare Advantage (MA) and prescription drug plans (PDPs) that runs from October 15th through December 7th of each year. Plans then begin to analyze final enrollment results in February and March to evaluate their standing and assess which competitors gained and lost members. As of March 1, 2021, total Medicare Advantage (MA), including Medicare Advantage with Prescription Drug Plan (MA-PD) membership, stood at 27,158,911 with a net gain of 2,408,192 members from March 1, 2020. Medicare stand-alone prescription drug plans (PDPs) covered 24,268,611 members as of March 1, 2021, a net decrease of 926,333 from the previous year.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Aetna (United States), El Paso Health Advantage (United States), Reliance Medicare Advantage (India), PHP Medicare (United States), Community Health Choice (United States), Anthem (United States), Clarion Health (United States), Humana (United States), Mary Washington Medicare Advantage (United States), Troy Health Inc. (United States), MoreCare (United States), Zing Health (United States), Experience Health, Inc. (United States), Kaiser Permanente (United States), Constellation Health (United States) and ApexHealth, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Dignity Health Plan (United States), Cigna (United States), UnitedHealthcare Group (United States) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Medicare Advantage market by Type (Health maintenance organizations (HMO), Preferred Provider Organizations (PPO), Special Need Plans and Private Fee For Service, Medical Savings Accounts and Others), Application (Agents or Brokers and Direct Writing) and Region.



On the basis of geography, the market of Medicare Advantage has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Introduction of Technology in Insurance Processing, Emerging Popularity of Medicare Insurance for Medicare Part D which Covers Prescription Drug and Surging Government Programs for Medicare Insurance

Market Growth Drivers:
Need for Medicare Insurance among 65 Year or Older People, High Healthcare Costs are Fuelling the Market Growth and Demand for Low Premium Insurance

Challenges:
Lack of Awareness about the Medicare Advantages

Restraints:
Strict Regulatory Guidelines on the Medicare

Opportunities:
Advancement in Delivery of Medicare Insurance, Growing Sales Channel for Insurance and Increasing Promotional Activities

Market Leaders and their expansionary development strategies
In January 2024, HCSC has signed a definitive agreement with The Cigna Group to acquire its Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D and CareAllies businesses. The acquisition will benefit HCSC’s current and future members by enhancing the company’s capabilities and reach, particularly in the growing Medicare segment.
In January 2024, Biden-Harris Administration announced new actions to promote competition in health care, including increasing transparency in the Medicare Advantage (MA) insurance market and strengthening MA programmatic data.


Key Target Audience
Providers of Medicare Advantage, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Health maintenance organizations (HMO)
  • Preferred Provider Organizations (PPO)
  • Special Need Plans and Private Fee For Service
  • Medical Savings Accounts
  • Others
By Application
  • Agents or Brokers
  • Direct Writing
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Need for Medicare Insurance among 65 Year or Older People
      • 3.2.2. High Healthcare Costs are Fuelling the Market Growth
      • 3.2.3. Demand for Low Premium Insurance
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about the Medicare Advantages
    • 3.4. Market Trends
      • 3.4.1. Introduction of Technology in Insurance Processing
      • 3.4.2. Emerging Popularity of Medicare Insurance for Medicare Part D which Covers Prescription Drug
      • 3.4.3. Surging Government Programs for Medicare Insurance
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medicare Advantage, by Type, Application and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Medicare Advantage (Value)
      • 5.2.1. Global Medicare Advantage by: Type (Value)
        • 5.2.1.1. Health maintenance organizations (HMO)
        • 5.2.1.2. Preferred Provider Organizations (PPO)
        • 5.2.1.3. Special Need Plans and Private Fee For Service
        • 5.2.1.4. Medical Savings Accounts
        • 5.2.1.5. Others
      • 5.2.2. Global Medicare Advantage by: Application (Value)
        • 5.2.2.1. Agents or Brokers
        • 5.2.2.2. Direct Writing
      • 5.2.3. Global Medicare Advantage Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Medicare Advantage (Price)
      • 5.3.1. Global Medicare Advantage by: Type (Price)
  • 6. Medicare Advantage: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Aetna (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. El Paso Health Advantage (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Reliance Medicare Advantage (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PHP Medicare (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Community Health Choice (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Anthem (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Clarion Health (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Humana (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mary Washington Medicare Advantage (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Troy Health Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. MoreCare (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Zing Health (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Experience Health, Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Kaiser Permanente (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Constellation Health (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. ApexHealth, Inc. (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Medicare Advantage Sale, by Type, Application and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Medicare Advantage (Value)
      • 7.2.1. Global Medicare Advantage by: Type (Value)
        • 7.2.1.1. Health maintenance organizations (HMO)
        • 7.2.1.2. Preferred Provider Organizations (PPO)
        • 7.2.1.3. Special Need Plans and Private Fee For Service
        • 7.2.1.4. Medical Savings Accounts
        • 7.2.1.5. Others
      • 7.2.2. Global Medicare Advantage by: Application (Value)
        • 7.2.2.1. Agents or Brokers
        • 7.2.2.2. Direct Writing
      • 7.2.3. Global Medicare Advantage Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Medicare Advantage (Price)
      • 7.3.1. Global Medicare Advantage by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medicare Advantage: by Type(USD Million)
  • Table 2. Medicare Advantage Health maintenance organizations (HMO) , by Region USD Million (2018-2023)
  • Table 3. Medicare Advantage Preferred Provider Organizations (PPO) , by Region USD Million (2018-2023)
  • Table 4. Medicare Advantage Special Need Plans and Private Fee For Service , by Region USD Million (2018-2023)
  • Table 5. Medicare Advantage Medical Savings Accounts , by Region USD Million (2018-2023)
  • Table 6. Medicare Advantage Others , by Region USD Million (2018-2023)
  • Table 7. Medicare Advantage: by Application(USD Million)
  • Table 8. Medicare Advantage Agents or Brokers , by Region USD Million (2018-2023)
  • Table 9. Medicare Advantage Direct Writing , by Region USD Million (2018-2023)
  • Table 10. South America Medicare Advantage, by Country USD Million (2018-2023)
  • Table 11. South America Medicare Advantage, by Type USD Million (2018-2023)
  • Table 12. South America Medicare Advantage, by Application USD Million (2018-2023)
  • Table 13. Brazil Medicare Advantage, by Type USD Million (2018-2023)
  • Table 14. Brazil Medicare Advantage, by Application USD Million (2018-2023)
  • Table 15. Argentina Medicare Advantage, by Type USD Million (2018-2023)
  • Table 16. Argentina Medicare Advantage, by Application USD Million (2018-2023)
  • Table 17. Rest of South America Medicare Advantage, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Medicare Advantage, by Application USD Million (2018-2023)
  • Table 19. Asia Pacific Medicare Advantage, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Medicare Advantage, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Medicare Advantage, by Application USD Million (2018-2023)
  • Table 22. China Medicare Advantage, by Type USD Million (2018-2023)
  • Table 23. China Medicare Advantage, by Application USD Million (2018-2023)
  • Table 24. Japan Medicare Advantage, by Type USD Million (2018-2023)
  • Table 25. Japan Medicare Advantage, by Application USD Million (2018-2023)
  • Table 26. India Medicare Advantage, by Type USD Million (2018-2023)
  • Table 27. India Medicare Advantage, by Application USD Million (2018-2023)
  • Table 28. South Korea Medicare Advantage, by Type USD Million (2018-2023)
  • Table 29. South Korea Medicare Advantage, by Application USD Million (2018-2023)
  • Table 30. Taiwan Medicare Advantage, by Type USD Million (2018-2023)
  • Table 31. Taiwan Medicare Advantage, by Application USD Million (2018-2023)
  • Table 32. Australia Medicare Advantage, by Type USD Million (2018-2023)
  • Table 33. Australia Medicare Advantage, by Application USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Medicare Advantage, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Medicare Advantage, by Application USD Million (2018-2023)
  • Table 36. Europe Medicare Advantage, by Country USD Million (2018-2023)
  • Table 37. Europe Medicare Advantage, by Type USD Million (2018-2023)
  • Table 38. Europe Medicare Advantage, by Application USD Million (2018-2023)
  • Table 39. Germany Medicare Advantage, by Type USD Million (2018-2023)
  • Table 40. Germany Medicare Advantage, by Application USD Million (2018-2023)
  • Table 41. France Medicare Advantage, by Type USD Million (2018-2023)
  • Table 42. France Medicare Advantage, by Application USD Million (2018-2023)
  • Table 43. Italy Medicare Advantage, by Type USD Million (2018-2023)
  • Table 44. Italy Medicare Advantage, by Application USD Million (2018-2023)
  • Table 45. United Kingdom Medicare Advantage, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Medicare Advantage, by Application USD Million (2018-2023)
  • Table 47. Netherlands Medicare Advantage, by Type USD Million (2018-2023)
  • Table 48. Netherlands Medicare Advantage, by Application USD Million (2018-2023)
  • Table 49. Rest of Europe Medicare Advantage, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Medicare Advantage, by Application USD Million (2018-2023)
  • Table 51. MEA Medicare Advantage, by Country USD Million (2018-2023)
  • Table 52. MEA Medicare Advantage, by Type USD Million (2018-2023)
  • Table 53. MEA Medicare Advantage, by Application USD Million (2018-2023)
  • Table 54. Middle East Medicare Advantage, by Type USD Million (2018-2023)
  • Table 55. Middle East Medicare Advantage, by Application USD Million (2018-2023)
  • Table 56. Africa Medicare Advantage, by Type USD Million (2018-2023)
  • Table 57. Africa Medicare Advantage, by Application USD Million (2018-2023)
  • Table 58. North America Medicare Advantage, by Country USD Million (2018-2023)
  • Table 59. North America Medicare Advantage, by Type USD Million (2018-2023)
  • Table 60. North America Medicare Advantage, by Application USD Million (2018-2023)
  • Table 61. United States Medicare Advantage, by Type USD Million (2018-2023)
  • Table 62. United States Medicare Advantage, by Application USD Million (2018-2023)
  • Table 63. Canada Medicare Advantage, by Type USD Million (2018-2023)
  • Table 64. Canada Medicare Advantage, by Application USD Million (2018-2023)
  • Table 65. Mexico Medicare Advantage, by Type USD Million (2018-2023)
  • Table 66. Mexico Medicare Advantage, by Application USD Million (2018-2023)
  • Table 67. Medicare Advantage: by Type(USD/Units)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Medicare Advantage: by Type(USD Million)
  • Table 85. Medicare Advantage Health maintenance organizations (HMO) , by Region USD Million (2025-2030)
  • Table 86. Medicare Advantage Preferred Provider Organizations (PPO) , by Region USD Million (2025-2030)
  • Table 87. Medicare Advantage Special Need Plans and Private Fee For Service , by Region USD Million (2025-2030)
  • Table 88. Medicare Advantage Medical Savings Accounts , by Region USD Million (2025-2030)
  • Table 89. Medicare Advantage Others , by Region USD Million (2025-2030)
  • Table 90. Medicare Advantage: by Application(USD Million)
  • Table 91. Medicare Advantage Agents or Brokers , by Region USD Million (2025-2030)
  • Table 92. Medicare Advantage Direct Writing , by Region USD Million (2025-2030)
  • Table 93. South America Medicare Advantage, by Country USD Million (2025-2030)
  • Table 94. South America Medicare Advantage, by Type USD Million (2025-2030)
  • Table 95. South America Medicare Advantage, by Application USD Million (2025-2030)
  • Table 96. Brazil Medicare Advantage, by Type USD Million (2025-2030)
  • Table 97. Brazil Medicare Advantage, by Application USD Million (2025-2030)
  • Table 98. Argentina Medicare Advantage, by Type USD Million (2025-2030)
  • Table 99. Argentina Medicare Advantage, by Application USD Million (2025-2030)
  • Table 100. Rest of South America Medicare Advantage, by Type USD Million (2025-2030)
  • Table 101. Rest of South America Medicare Advantage, by Application USD Million (2025-2030)
  • Table 102. Asia Pacific Medicare Advantage, by Country USD Million (2025-2030)
  • Table 103. Asia Pacific Medicare Advantage, by Type USD Million (2025-2030)
  • Table 104. Asia Pacific Medicare Advantage, by Application USD Million (2025-2030)
  • Table 105. China Medicare Advantage, by Type USD Million (2025-2030)
  • Table 106. China Medicare Advantage, by Application USD Million (2025-2030)
  • Table 107. Japan Medicare Advantage, by Type USD Million (2025-2030)
  • Table 108. Japan Medicare Advantage, by Application USD Million (2025-2030)
  • Table 109. India Medicare Advantage, by Type USD Million (2025-2030)
  • Table 110. India Medicare Advantage, by Application USD Million (2025-2030)
  • Table 111. South Korea Medicare Advantage, by Type USD Million (2025-2030)
  • Table 112. South Korea Medicare Advantage, by Application USD Million (2025-2030)
  • Table 113. Taiwan Medicare Advantage, by Type USD Million (2025-2030)
  • Table 114. Taiwan Medicare Advantage, by Application USD Million (2025-2030)
  • Table 115. Australia Medicare Advantage, by Type USD Million (2025-2030)
  • Table 116. Australia Medicare Advantage, by Application USD Million (2025-2030)
  • Table 117. Rest of Asia-Pacific Medicare Advantage, by Type USD Million (2025-2030)
  • Table 118. Rest of Asia-Pacific Medicare Advantage, by Application USD Million (2025-2030)
  • Table 119. Europe Medicare Advantage, by Country USD Million (2025-2030)
  • Table 120. Europe Medicare Advantage, by Type USD Million (2025-2030)
  • Table 121. Europe Medicare Advantage, by Application USD Million (2025-2030)
  • Table 122. Germany Medicare Advantage, by Type USD Million (2025-2030)
  • Table 123. Germany Medicare Advantage, by Application USD Million (2025-2030)
  • Table 124. France Medicare Advantage, by Type USD Million (2025-2030)
  • Table 125. France Medicare Advantage, by Application USD Million (2025-2030)
  • Table 126. Italy Medicare Advantage, by Type USD Million (2025-2030)
  • Table 127. Italy Medicare Advantage, by Application USD Million (2025-2030)
  • Table 128. United Kingdom Medicare Advantage, by Type USD Million (2025-2030)
  • Table 129. United Kingdom Medicare Advantage, by Application USD Million (2025-2030)
  • Table 130. Netherlands Medicare Advantage, by Type USD Million (2025-2030)
  • Table 131. Netherlands Medicare Advantage, by Application USD Million (2025-2030)
  • Table 132. Rest of Europe Medicare Advantage, by Type USD Million (2025-2030)
  • Table 133. Rest of Europe Medicare Advantage, by Application USD Million (2025-2030)
  • Table 134. MEA Medicare Advantage, by Country USD Million (2025-2030)
  • Table 135. MEA Medicare Advantage, by Type USD Million (2025-2030)
  • Table 136. MEA Medicare Advantage, by Application USD Million (2025-2030)
  • Table 137. Middle East Medicare Advantage, by Type USD Million (2025-2030)
  • Table 138. Middle East Medicare Advantage, by Application USD Million (2025-2030)
  • Table 139. Africa Medicare Advantage, by Type USD Million (2025-2030)
  • Table 140. Africa Medicare Advantage, by Application USD Million (2025-2030)
  • Table 141. North America Medicare Advantage, by Country USD Million (2025-2030)
  • Table 142. North America Medicare Advantage, by Type USD Million (2025-2030)
  • Table 143. North America Medicare Advantage, by Application USD Million (2025-2030)
  • Table 144. United States Medicare Advantage, by Type USD Million (2025-2030)
  • Table 145. United States Medicare Advantage, by Application USD Million (2025-2030)
  • Table 146. Canada Medicare Advantage, by Type USD Million (2025-2030)
  • Table 147. Canada Medicare Advantage, by Application USD Million (2025-2030)
  • Table 148. Mexico Medicare Advantage, by Type USD Million (2025-2030)
  • Table 149. Mexico Medicare Advantage, by Application USD Million (2025-2030)
  • Table 150. Medicare Advantage: by Type(USD/Units)
  • Table 151. Research Programs/Design for This Report
  • Table 152. Key Data Information from Secondary Sources
  • Table 153. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medicare Advantage: by Type USD Million (2018-2023)
  • Figure 5. Global Medicare Advantage: by Application USD Million (2018-2023)
  • Figure 6. South America Medicare Advantage Share (%), by Country
  • Figure 7. Asia Pacific Medicare Advantage Share (%), by Country
  • Figure 8. Europe Medicare Advantage Share (%), by Country
  • Figure 9. MEA Medicare Advantage Share (%), by Country
  • Figure 10. North America Medicare Advantage Share (%), by Country
  • Figure 11. Global Medicare Advantage: by Type USD/Units (2018-2023)
  • Figure 12. Global Medicare Advantage share by Players 2023 (%)
  • Figure 13. Global Medicare Advantage share by Players (Top 3) 2023(%)
  • Figure 14. Global Medicare Advantage share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Aetna (United States) Revenue, Net Income and Gross profit
  • Figure 17. Aetna (United States) Revenue: by Geography 2023
  • Figure 18. El Paso Health Advantage (United States) Revenue, Net Income and Gross profit
  • Figure 19. El Paso Health Advantage (United States) Revenue: by Geography 2023
  • Figure 20. Reliance Medicare Advantage (India) Revenue, Net Income and Gross profit
  • Figure 21. Reliance Medicare Advantage (India) Revenue: by Geography 2023
  • Figure 22. PHP Medicare (United States) Revenue, Net Income and Gross profit
  • Figure 23. PHP Medicare (United States) Revenue: by Geography 2023
  • Figure 24. Community Health Choice (United States) Revenue, Net Income and Gross profit
  • Figure 25. Community Health Choice (United States) Revenue: by Geography 2023
  • Figure 26. Anthem (United States) Revenue, Net Income and Gross profit
  • Figure 27. Anthem (United States) Revenue: by Geography 2023
  • Figure 28. Clarion Health (United States) Revenue, Net Income and Gross profit
  • Figure 29. Clarion Health (United States) Revenue: by Geography 2023
  • Figure 30. Humana (United States) Revenue, Net Income and Gross profit
  • Figure 31. Humana (United States) Revenue: by Geography 2023
  • Figure 32. Mary Washington Medicare Advantage (United States) Revenue, Net Income and Gross profit
  • Figure 33. Mary Washington Medicare Advantage (United States) Revenue: by Geography 2023
  • Figure 34. Troy Health Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Troy Health Inc. (United States) Revenue: by Geography 2023
  • Figure 36. MoreCare (United States) Revenue, Net Income and Gross profit
  • Figure 37. MoreCare (United States) Revenue: by Geography 2023
  • Figure 38. Zing Health (United States) Revenue, Net Income and Gross profit
  • Figure 39. Zing Health (United States) Revenue: by Geography 2023
  • Figure 40. Experience Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Experience Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 42. Kaiser Permanente (United States) Revenue, Net Income and Gross profit
  • Figure 43. Kaiser Permanente (United States) Revenue: by Geography 2023
  • Figure 44. Constellation Health (United States) Revenue, Net Income and Gross profit
  • Figure 45. Constellation Health (United States) Revenue: by Geography 2023
  • Figure 46. ApexHealth, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 47. ApexHealth, Inc. (United States) Revenue: by Geography 2023
  • Figure 48. Global Medicare Advantage: by Type USD Million (2025-2030)
  • Figure 49. Global Medicare Advantage: by Application USD Million (2025-2030)
  • Figure 50. South America Medicare Advantage Share (%), by Country
  • Figure 51. Asia Pacific Medicare Advantage Share (%), by Country
  • Figure 52. Europe Medicare Advantage Share (%), by Country
  • Figure 53. MEA Medicare Advantage Share (%), by Country
  • Figure 54. North America Medicare Advantage Share (%), by Country
  • Figure 55. Global Medicare Advantage: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Aetna (United States)
  • El Paso Health Advantage (United States)
  • Reliance Medicare Advantage (India)
  • PHP Medicare (United States)
  • Community Health Choice (United States)
  • Anthem (United States)
  • Clarion Health (United States)
  • Humana (United States)
  • Mary Washington Medicare Advantage (United States)
  • Troy Health Inc. (United States)
  • MoreCare (United States)
  • Zing Health (United States)
  • Experience Health, Inc. (United States)
  • Kaiser Permanente (United States)
  • Constellation Health (United States)
  • ApexHealth, Inc. (United States)
Additional players considered in the study are as follows:
Dignity Health Plan (United States) , Cigna (United States) , UnitedHealthcare Group (United States) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 237 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medicare Advantage Quantitative research analysis
Global Medicare Advantage Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Aetna (United States), El Paso Health Advantage (United States), Reliance Medicare Advantage (India), PHP Medicare (United States), Community Health Choice (United States), Anthem (United States), Clarion Health (United States), Humana (United States), Mary Washington Medicare Advantage (United States), Troy Health Inc. (United States), MoreCare (United States), Zing Health (United States), Experience Health, Inc. (United States), Kaiser Permanente (United States), Constellation Health (United States) and ApexHealth, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Introduction of Technology in Insurance Processing " is seen as one of major influencing trends for Medicare Advantage Market during projected period 2023-2030.
The Medicare Advantage market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Medicare Advantage Report?

Have a Query? Click Here

Other Related Reports

Viral Gene Therapy Comprehensive Study by Vector Type (Viral Vector {Lentivirus, Adeno-Associated Virus, Retrovirus & Gamma retrovirus, Modified Herpes Simplex, Adenovirus Virus}, Non-Viral Vector {O...
$ 3750
Canker Sores Drug Comprehensive Study by Type (Ointment, Spray, Pills, Patch, Mouthwash), Application (Hospital, Clinics, Drug Store), Packaging Type (Plastic, Aluminum, PE bottles, Glass, Others), F...
$ 3450
Scalp Care Treatment Comprehensive Study by Type (Medicated, Non-Medicated), Drug Type (Branded, Generics), Distribution Channel (Supermarket, Specialty Store, Pharmacy Store, Conventional Stores, On...
$ 3750
Stool Softeners Comprehensive Study by Type (Soft gel capsules, Oral liquids, Tablet, Chewable, Flake, Powder, Others), Distribution Channel (Pharmacy Stores, Online Stores, Hospitals, Clinics, Other...
$ 3450
Coccidiosis Treatment Comprehensive Study by Type (Sulfadimethoxine, Sulfaguanidine, Furazolidone, Trimethoprim/Sulfonamide, Others), Application (Poultry, Dog, Fish, Cat, Cattle, Others), Consumptio...
$ 3450
Scleroderma Therapy Comprehensive Study by Type (Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues,...
$ 3650